Italian glass manufacturer Bormioli Pharma plans to use 50% of sustainable raw materials for the manufacture of its products by 2025, tripling its current usage.
Despite the highly regulated nature of the pharmaceutical industry which makes making change more complex, the sector seems to be ready to embrace the challenge of the ecological transition.
According to a survey conducted by Bormioli Pharma on its customer base, more than 90% of companies in the pharmaceutical sector consider the quest for new sustainable packaging solutions a priority.
This focus has already translated into an increase in the sales of bottles, closures and accessories made from recycled or bio-based materials, which reached +50% in 2020 and +130% in the last three years.
These are results the company has been able to achieve thanks to its ability to combine sustainable materials with the quality and safety standards required by the industry.
“Sustainability is quickly becoming an agenda point of pharmaceutical industries around the world and, as primary packaging manufacturers, we feel the responsibility to support the industry in this transition, while sustaining the health of people and the planet,” said Andrea Lodetti, CEO of Bormioli Pharma.
Other solutions are currently being developed and tested, such as the creation of a plastic made from carbon emissions recovery, the introduction of eco-design guidelines that encourage a lower use of virgin materials, the simplification of components and enhanced recycling.